Table 1 Demographic and clinical data of RRMS patients and healthy controls.

From: Analysis of the entire mitochondrial genome reveals Leber’s hereditary optic neuropathy mitochondrial DNA mutations in an Arab cohort with multiple sclerosis

 

Patients (n = 23)

Controls (n = 24)

Age (mean ± SD)

28 ± 7.5

31 ± 7.5

Gender ratio (male/female)

5/18

5/19

BMI (mean ± SD)

27 ± 6.2

29 ± 5.5

Blood pressure (mean ± SD)

Systolic

123 ± 11.4

131 ± 16.4

Diastolic

72 ± 11.9

76 ± 9.6

Disease duration (mean ± SD)/range

5.3 ± 4.0/(1–15)

 

EDSS (mean ± SD)/range

3.9 ± 1.4/(2–6.5)

 

Medication

Avonex

3

 

Betaferon

8

 

Glienya

3

 

Rebif

5

 

Tysabri

4

 
  1. RRMS relapse-remitting multiple sclerosis, EDSS Expanded Disability Status Scale. Data are presented as number or mean ± standard deviation (SD).
Back to article page